Ziegler, D. S., Wong, M., Mayoh, C., Kumar, A., Tsoli, M., Mould, E., . . . Haber, M. (2018). Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. British journal of cancer, 119(6), 693-696. https://doi.org/10.1038/s41416-018-0251-2
Citace podle Chicago (17th ed.)Ziegler, David S., et al. "Brief Report: Potent Clinical and Radiological Response to Larotrectinib in TRK Fusion-driven High-grade Glioma." British Journal of Cancer 119, no. 6 (2018): 693-696. https://doi.org/10.1038/s41416-018-0251-2.
Citace podle MLA (9th ed.)Ziegler, David S., et al. "Brief Report: Potent Clinical and Radiological Response to Larotrectinib in TRK Fusion-driven High-grade Glioma." British Journal of Cancer, vol. 119, no. 6, 2018, pp. 693-696, https://doi.org/10.1038/s41416-018-0251-2.